Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Adanate on the deal. Adanate, a biotech company focusing on therapies in oncology and immunology, recently raised $30 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Sorriso Pharmaceuticals on the deal. Sorriso Pharmaceuticals, a biotechnology company advancing a pipeline of disease-modifying antibodies for the treatment of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Capsigen Inc. on the deal. Biogen Inc. and Capsigen Inc. announced they have entered into a strategic research collaboration to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Excision BioTherapeutics on the deal. Excision BioTherapeutics, a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives,...
You must be a Standard 1 Year member to access this content.
